News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Bristol-Myers Squibb Company To Pay $300 Million In Settlement
October 19, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Drug giant Bristol-Myers Squibb Co. said Friday it will pay $300 million to settle a class-action lawsuit that accused the company of lying about accounting and its investment in ImClone Systems Inc.
Twitter
LinkedIn
Facebook
Email
Print
Legal
Bristol Myers Squibb Company
MORE ON THIS TOPIC
Drug pricing
TrumpRx Delayed Amid Potential Anti-Kickback Concerns
January 30, 2026
·
2 min read
·
Tristan Manalac
Legal
CytoDyn’s Former CEO Gets Jail Time, $5.3M+ Fine for Securities Fraud
January 27, 2026
·
2 min read
·
Tristan Manalac
Manufacturing
Big Pharma Tight-Lipped on Details of API Stockpile Deals
January 27, 2026
·
4 min read
·
Nick Paul Taylor
Rare diseases
Rare Disease Biotechs Stand To Lose $4B if Priority Voucher Program Not Reinstated: Report
January 26, 2026
·
7 min read
·
Heather McKenzie
